This is a preview of subscription content, log in via an institution to check access.
Reference
Johnson KT, et al. Cost-effectiveness of preventive therapy for tuberculosis with isoniazid and rifapentine versus isoniazid alone in high-burden settings. Clinical Infectious Diseases : 30 Mar 2018. Available from: URL: http://doi.org/10.1093/cid/ciy230
Rights and permissions
About this article
Cite this article
Rifapentine + isoniazid − cost effective for TB prevention?. PharmacoEcon Outcomes News 801, 30 (2018). https://doi.org/10.1007/s40274-018-4885-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4885-3